A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Donald Trump's revised immigration ban targets the same seven Muslim majority countries listed in his original executive order, sources say.
People convicted of cruelty against animals should face much harsher prison sentences, some charities have claimed.
Theresa May has been warned by EU ministers that Britain's Brexit negotiators must be prepared to compromise or risk a "crash landing".